Sabby Management, LLC Hepion Pharmaceuticals, Inc. Transaction History

Sabby Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.93 - $1.29 $19,045 - $26,417	-20,479 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.14 - $1.58 $23,346 - $32,356	20,479 New	20,479 $23,000
Q2 2021 Aug 16, 2021	SELL	$1.56 - $2.26 $477,887 - $692,323	-306,338 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.77 - $2.98 $542,218 - $912,887	306,338 New	306,338 $564,000
Q4 2020 Feb 16, 2021	SELL	$1.58 - $3.64 $90,548 - $208,604	-57,309 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.84 - $4.59 $162,757 - $263,048	57,309 New	57,309 $178,000
Q2 2020 Aug 14, 2020	SELL	$1.31 - $3.09 $95,073 - $224,256	-72,575 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.15 - $5.74 $83,461 - $416,580	72,575 New	72,575 $128,000
Q4 2019 Feb 14, 2020	SELL	$2.25 - $6.99 $258,750 - $803,850	-115,000 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$2.09 - $4.12 $240,349 - $473,800	115,000 New	115,000 $278,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $54.9M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.